Premium
TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has increased its exposure to a bulk-drugs company that was its second pharmaceuticals bet in India. The investment firm has picked up a 4.4% stake in Solara Active Pharma Sciences Ltd for Rs 60-65 crore ($8.48-9.18 million) through ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
